For weight management, these medications are typically prescribed for people with a BMI of 30 or higher, or 27 or higher with a weight-related health condition like diabetes, obstructive sleep apnea or high blood pressure
Medical supervision is essential for any pharmacotherapy, as unregulated use carries risks of contamination, dosing errors, and adverse events
Diagnosis and treatment of MDD are limited due to the absence of biomarkers underlying the pathophysiological mechanisms of MDD
Gut microbiota and autism spectrum disorders: A bidirectional mendelian randomization study
Some possible reasons for this link: the stress of weight stigma creates dysregulation across many physiological systems (including the cardiovascular, metabolic, and the sympathetic and parasympathetic nervous systems), and weight cycling has been shown to create an increased inflammatory response and impaired glucose response in mice
Everything that makes BPC-157 work or fail comes down to the source and the provider